The objective of the study is to assess the feasibility of increasing dose of irradiation
with IMRT using a SIB approach over 6 weeks.
The primary endpoint of the study will be acute toxicity assessed during treatment and during
the first 3 months following the completion of radiotherapy The secondary endpoint will
include loco-regional control, disease-free survival, survival and late toxicity at 2 years
after completion of radiotherapy
Phase:
Phase 2
Details
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain